Remy S. Petersen MD , Lauré M. Fijen MD, PhD , Laurens E. Franssen MD, PhD , Josephine M.I. Vos MD, PhD , Danny M. Cohn MD, PhD
{"title":"基于达拉单抗治疗获得性 C1 抑制剂缺乏引起的单克隆抗体病相关性血管性水肿","authors":"Remy S. Petersen MD , Lauré M. Fijen MD, PhD , Laurens E. Franssen MD, PhD , Josephine M.I. Vos MD, PhD , Danny M. Cohn MD, PhD","doi":"10.1016/j.jacig.2024.100322","DOIUrl":null,"url":null,"abstract":"<div><p>Daratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy.</p></div>","PeriodicalId":75041,"journal":{"name":"The journal of allergy and clinical immunology. Global","volume":"3 4","pages":"Article 100322"},"PeriodicalIF":0.0000,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772829324001188/pdfft?md5=495b758957b0ee1664e2af5c3017b3cf&pid=1-s2.0-S2772829324001188-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency\",\"authors\":\"Remy S. Petersen MD , Lauré M. Fijen MD, PhD , Laurens E. Franssen MD, PhD , Josephine M.I. Vos MD, PhD , Danny M. Cohn MD, PhD\",\"doi\":\"10.1016/j.jacig.2024.100322\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Daratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy.</p></div>\",\"PeriodicalId\":75041,\"journal\":{\"name\":\"The journal of allergy and clinical immunology. Global\",\"volume\":\"3 4\",\"pages\":\"Article 100322\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-08-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2772829324001188/pdfft?md5=495b758957b0ee1664e2af5c3017b3cf&pid=1-s2.0-S2772829324001188-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The journal of allergy and clinical immunology. Global\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2772829324001188\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The journal of allergy and clinical immunology. Global","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772829324001188","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Daratumumab-based treatment of monoclonal gammopathy–associated angioedema due to acquired C1-inhibitor deficiency
Daratumumab-based treatment could control severe, treatment-refractory, life-threatening angioedema due to acquired C1-inhibitor deficiency associated with monoclonal gammopathy.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
